Procter & Gamble Hygiene and Health Care Limited (BOM:500459)
India · Delayed Price · Currency is INR 8,590.30
+113.80 (1.34%)
At close: Jul 31, 2026
BOM:500459 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | 8,565 | 8,488 | 6,750 | 6,781 | 5,758 |
Depreciation & Amortization | 374.3 | 425.87 | 565 | 583.6 | 528.8 |
Loss (Gain) From Sale of Assets | -20.5 | 3.07 | 55.4 | 8.3 | 17.6 |
Asset Writedown & Restructuring Costs | - | - | 130.3 | - | - |
Stock-Based Compensation | 53.4 | 81.6 | 85 | 84.8 | 101.5 |
Provision & Write-off of Bad Debts | 6.5 | 41.47 | 9.9 | 10.9 | 4.1 |
Other Operating Activities | -112.3 | -368 | -434.4 | -866.5 | -425.6 |
Change in Accounts Receivable | 621.8 | -875.47 | -255.4 | -251.1 | -488.6 |
Change in Inventory | -105.8 | -77.47 | -183.7 | 52.6 | 66.2 |
Change in Accounts Payable | 309.6 | -564.8 | -1,160 | 2,070 | 291.1 |
Change in Other Net Operating Assets | -451.2 | 755.33 | -862.1 | -215.8 | -121.6 |
Operating Cash Flow | 9,241 | 7,909 | 4,700 | 8,258 | 5,731 |
Operating Cash Flow Growth | 16.83% | 68.28% | -43.08% | 44.09% | -33.60% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -495.4 | -733.73 | -446.8 | -444.4 | -498 |
Sale of Property, Plant & Equipment | 182.2 | 5.47 | 14.1 | 0.2 | 0.7 |
Other Investing Activities | 426.9 | 271.2 | 443.3 | 345.1 | 228.8 |
Investing Cash Flow | 113.7 | -457.07 | 10.6 | -99.1 | -268.5 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Issued | - | - | - | - | 16.3 |
Long-Term Debt Repaid | - | - | -9.5 | -10.7 | - |
Total Debt Repaid | - | -10.13 | -9.5 | -10.7 | - |
Net Debt Issued (Repaid) | - | -10.13 | -9.5 | -10.7 | 16.3 |
Common Dividends Paid | -8,440 | -8,873 | -8,602 | -4,707 | -5,681 |
Other Financing Activities | -8.3 | -0.27 | -0.8 | -52.6 | -25.1 |
Financing Cash Flow | -8,448 | -8,883 | -8,612 | -4,770 | -5,689 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Cash Flow | 906.5 | -1,431 | -3,902 | 3,389 | -226.9 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 8,745 | 7,176 | 4,253 | 7,813 | 5,233 |
Free Cash Flow Growth | 21.88% | 68.71% | -45.56% | 49.31% | -37.07% |
Free Cash Flow Margin | 20.38% | 16.66% | 10.11% | 19.94% | 13.41% |
Free Cash Flow Per Share | 269.42 | 221.06 | 131.03 | 240.70 | 161.21 |
Levered Free Cash Flow | 7,959 | - | 4,126 | 7,398 | 4,998 |
Unlevered Free Cash Flow | 8,018 | - | 4,253 | 7,431 | 5,035 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 8.3 | 0.27 | 0.8 | 52.6 | 25.1 |
Cash Income Tax Paid | 3,019 | 3,241 | 2,977 | 2,295 | 2,494 |
Change in Working Capital | 374.4 | -762.4 | -2,461 | 1,655 | -252.9 |